Iovanace Biotherapeutics (IOVA) PT Lowered to $19 at Goldman Sachs
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Price: $7.10 +1.72%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Goldman Sachs analyst Andrea Tan lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $19.00 (from $22.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
